Cell Source Stock Analysis

Cell Pink Sheet Analysis Notes

About 32.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.2. Cell Source had not issued any dividends in recent years. Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. Cell Source, Inc. was founded in 2012 and is headquartered in New York, New York. Cell Source operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.The quote for Cell Source is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Cell Source please contact Itamar Shimrat at 646 416 7896 or go to https://www.cell-source.com.

Cell Source Investment Alerts

Cell Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cell Source's market, we take the total number of its shares issued and multiply it by Cell Source's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 5th of May, Cell Source shows the Risk Adjusted Performance of 0.0066, mean deviation of 10.21, and Standard Deviation of 21.39. Cell Source technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Cell Source, which can be compared to its peers. Please confirm Cell Source standard deviation and value at risk to decide if Cell Source is priced correctly, providing market reflects its regular price of 2.0E-4 per share. As Cell Source appears to be a penny stock we also recommend to validate its jensen alpha numbers.

Cell Source Price Movement Analysis

Cell Source Predictive Daily Indicators

Cell Source Forecast Models

Cell Source's time-series forecasting models are one of many Cell Source's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cell Source's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Cell Source prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cell shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Cell Source. By using and applying Cell Pink Sheet analysis, traders can create a robust methodology for identifying Cell entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cell Source. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Cell Source information on this page should be used as a complementary analysis to other Cell Source's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

When running Cell Source's price analysis, check to measure Cell Source's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Source is operating at the current time. Most of Cell Source's value examination focuses on studying past and present price action to predict the probability of Cell Source's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Source's price. Additionally, you may evaluate how the addition of Cell Source to your portfolios can decrease your overall portfolio volatility.